Literature DB >> 25533909

Differential diagnosis of bipolar disorder and major depressive disorder.

R M Hirschfeld1.   

Abstract

BACKGROUND: Patients with bipolar disorder spend approximately half of their lives symptomatic and the majority of that time suffering from symptoms of depression, which complicates the accurate diagnosis of bipolar disorder.
METHODS: Challenges in the differential diagnosis of bipolar disorder and major depressive disorder are reviewed, and the clinical utility of several screening instruments is evaluated.
RESULTS: The estimated lifetime prevalence of major depressive disorder (i.e., unipolar depression) is over 3 and one-half times that of bipolar spectrum disorders. The clinical presentation of a major depressive episode in a bipolar disorder patient does not differ substantially from that of a patient with major depressive disorder (unipolar depression). Therefore, it is not surprising that without proper screening and comprehensive evaluation many patients with bipolar disorder may be misdiagnosed with major depressive disorder (unipolar depression). In general, antidepressants have demonstrated little or no efficacy for depressive episodes associated with bipolar disorder, and treatment guidelines recommend using antidepressants only as an adjunct to mood stabilizers for patients with bipolar disorder. Thus, correct identification of bipolar disorder among patients who present with depression is critical for providing appropriate treatment and improving patient outcomes. LIMITATIONS: Clinical characteristics indicative of bipolar disorder versus major depressive disorder identified in this review are based on group differences and may not apply to each individual patient.
CONCLUSION: The overview of demographic and clinical characteristics provided by this review may help medical professionals distinguish between major depressive disorder and bipolar disorder. Several validated, easily administered screening instruments are available and can greatly improve the recognition of bipolar disorder in patients with depression.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Depression; Diagnosis; Major depressive disorder; Screening

Mesh:

Substances:

Year:  2014        PMID: 25533909     DOI: 10.1016/S0165-0327(14)70004-7

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  41 in total

1.  Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.

Authors:  Leslie R Amodeo; Venuz Y Greenfield; Danielle E Humphrey; Veronica Varela; Joseph A Pipkin; Shannon E Eaton; Jelesa D Johnson; Christopher P Plant; Zachary R Harmony; Li Wang; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2015-07-05       Impact factor: 4.530

2.  Role of calcium channels in bipolar disorder.

Authors:  Stasia D'Onofrio; Susan Mahaffey; Edgar Garcia-Rill
Journal:  Curr Psychopharmacol       Date:  2017

3.  Distinguishing Bipolar Depression from Unipolar Depression in Youth: Preliminary Findings.

Authors:  Rasim Somer Diler; Tina R Goldstein; Danella Hafeman; John Merranko; Fangzi Liao; Benjamin I Goldstein; Heather Hower; Mary Kay Gill; Jeffrey Hunt; Shirley Yen; Martin B Keller; David Axelson; Michael Strober; Satish Iyengar; Neal D Ryan; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-02-28       Impact factor: 2.576

Review 4.  Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence.

Authors:  Xiaolu Zhang; Rawan S Alnafisah; Abdul-Rizaq A Hamoud; Rammohan Shukla; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Adv Neurobiol       Date:  2021

5.  Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression.

Authors:  Guoqing Zhao; Chen Zhang; Jun Chen; Yousong Su; Rubai Zhou; Fan Wang; Weiping Xia; Jia Huang; Zuowei Wang; Yingyan Hu; Lan Cao; Xiaoyun Guo; Chengmei Yuan; Yong Wang; Zhenghui Yi; Weihong Lu; Yan Wu; Zhiguo Wu; Wu Hong; Daihui Peng; Yiru Fang
Journal:  Mol Neurobiol       Date:  2016-09-09       Impact factor: 5.590

Review 6.  Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults.

Authors:  Amber Edinoff; Miriam T Ruoff; Yahya T Ghaffar; Arthur Rezayev; Devanshi Jani; Adam M Kaye; Elyse M Cornett; Alan D Kaye; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2020-09-14

7.  Disrupted Intersubject Variability Architecture in Functional Connectomes in Schizophrenia.

Authors:  Xiaoyi Sun; Jin Liu; Qing Ma; Jia Duan; Xindi Wang; Yuehua Xu; Zhilei Xu; Ke Xu; Fei Wang; Yanqing Tang; Yong He; Mingrui Xia
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

8.  Neutrophil-to-Lymphocyte Ratio, a Novel Inflammatory Marker, as a Predictor of Bipolar Type in Depressed Patients: A Quest for Biological Markers.

Authors:  Vlad Dionisie; Gabriela Adriana Filip; Mihnea Costin Manea; Robert Constantin Movileanu; Emanuel Moisa; Mirela Manea; Sorin Riga; Adela Magdalena Ciobanu
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

Review 9.  Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice.

Authors:  Amber N Edinoff; Natalie W Wu; Benjamin S Maxey; Amy L Ren; Kenna N Leethy; Brook Girma; Amira Odisho; Jessica S Kaye; Aaron J Kaye; Adam M Kaye; Alan D Kaye; George Mychaskiw; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-03-16

Review 10.  Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications.

Authors:  Amber N Edinoff; Nancy S Silverblatt; Hayley E Vervaeke; Cassidy C Horton; Eden Girma; Alan D Kaye; Adam Kaye; Jessica S Kaye; Andrew J Garcia; Elisa E Neuchat; Treniece N Eubanks; Giustino Varrassi; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.